Cargando…

Surgical outcomes of 215 patients with thymic epithelial tumors: A single‐center experience

OBJECTIVES: To evaluate the oncological prognosis and neurological outcomes for patients with thymic epithelial tumors (TETs) after thymectomy. METHODS: Consecutive patients with TETs who underwent thymectomy at Beijing Hospital from January 2011 to December 2018 were retrospectively enrolled into t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Wenxin, Sun, Yaoguang, Wu, Qingjun, Jiao, Peng, Ma, Chao, Yu, Hanbo, Huang, Chuan, Tong, Hongfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327686/
https://www.ncbi.nlm.nih.gov/pubmed/32384230
http://dx.doi.org/10.1111/1759-7714.13464
_version_ 1783552594817318912
author Tian, Wenxin
Sun, Yaoguang
Wu, Qingjun
Jiao, Peng
Ma, Chao
Yu, Hanbo
Huang, Chuan
Tong, Hongfeng
author_facet Tian, Wenxin
Sun, Yaoguang
Wu, Qingjun
Jiao, Peng
Ma, Chao
Yu, Hanbo
Huang, Chuan
Tong, Hongfeng
author_sort Tian, Wenxin
collection PubMed
description OBJECTIVES: To evaluate the oncological prognosis and neurological outcomes for patients with thymic epithelial tumors (TETs) after thymectomy. METHODS: Consecutive patients with TETs who underwent thymectomy at Beijing Hospital from January 2011 to December 2018 were retrospectively enrolled into the study. Clinical, pathological, and perioperative data was collected. Patients were followed‐up by telephone interview and outpatient records. Statistical analyses were performed using SPSS version 19.0. RESULTS: A total of 215 patients (115 men and 100 women) were included in this study of which 133 patients (61.9%) had TETs associated with myasthenia gravis (MG), and 82 patients (38.1%) had thymic tumors without MG. A total of 194 (90.2%) patients were successfully followed‐up. The median follow‐up period was 42 months. The five‐year overall survival (OS) rate was 88.6%. MG was the first cause of death for patients with MG (6/10). Prognosis in MG patients was similar to those without MG. Multivariate Cox regression analysis demonstrated that TNM stage III + IV was an independent risk factor for OS. Incomplete resection and younger age were risk factors for tumor recurrence. For patients with MG, the cumulative complete stable remission (CSR) rate increased with the postoperative follow‐up period, and the five‐year CSR rate was 44.7%. Univariate Cox analysis indicated that age, preoperative MG duration and preoperative medication might correlate with CSR. Multivariate Cox analysis only indicated older age as a negative factor of achieving CSR. CONCLUSIONS: MG had little influence on OS and tumor recurrence of thymic tumors. The new TNM staging system was an independent prognostic factor. Incomplete resection and younger age were risk factors for tumor recurrence. Older age was a negative factor of achieving CSR for thymoma patients with MG after extended thymectomy. KEY POINTS: SIGNIFICANT FINDINGS OF THE STUDY: MG was not a prognostic factor for thymic tumors. The new TNM staging system was useful for prediction of prognosis. Incomplete resection and younger age were risk factors for tumor recurrence. Older age led to a lower probability of achieving CSR for thymomatous MG. WHAT THIS STUDY ADDS: This study had a relatively large sample size of patients with thymic epithelial tumors in a single center. We evaluated not only the oncological prognosis, but also neurological outcomes after thymectomy, which was a more comprehensive assessment of surgical effect for thymic epithelial tumors.
format Online
Article
Text
id pubmed-7327686
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-73276862020-07-02 Surgical outcomes of 215 patients with thymic epithelial tumors: A single‐center experience Tian, Wenxin Sun, Yaoguang Wu, Qingjun Jiao, Peng Ma, Chao Yu, Hanbo Huang, Chuan Tong, Hongfeng Thorac Cancer Original Articles OBJECTIVES: To evaluate the oncological prognosis and neurological outcomes for patients with thymic epithelial tumors (TETs) after thymectomy. METHODS: Consecutive patients with TETs who underwent thymectomy at Beijing Hospital from January 2011 to December 2018 were retrospectively enrolled into the study. Clinical, pathological, and perioperative data was collected. Patients were followed‐up by telephone interview and outpatient records. Statistical analyses were performed using SPSS version 19.0. RESULTS: A total of 215 patients (115 men and 100 women) were included in this study of which 133 patients (61.9%) had TETs associated with myasthenia gravis (MG), and 82 patients (38.1%) had thymic tumors without MG. A total of 194 (90.2%) patients were successfully followed‐up. The median follow‐up period was 42 months. The five‐year overall survival (OS) rate was 88.6%. MG was the first cause of death for patients with MG (6/10). Prognosis in MG patients was similar to those without MG. Multivariate Cox regression analysis demonstrated that TNM stage III + IV was an independent risk factor for OS. Incomplete resection and younger age were risk factors for tumor recurrence. For patients with MG, the cumulative complete stable remission (CSR) rate increased with the postoperative follow‐up period, and the five‐year CSR rate was 44.7%. Univariate Cox analysis indicated that age, preoperative MG duration and preoperative medication might correlate with CSR. Multivariate Cox analysis only indicated older age as a negative factor of achieving CSR. CONCLUSIONS: MG had little influence on OS and tumor recurrence of thymic tumors. The new TNM staging system was an independent prognostic factor. Incomplete resection and younger age were risk factors for tumor recurrence. Older age was a negative factor of achieving CSR for thymoma patients with MG after extended thymectomy. KEY POINTS: SIGNIFICANT FINDINGS OF THE STUDY: MG was not a prognostic factor for thymic tumors. The new TNM staging system was useful for prediction of prognosis. Incomplete resection and younger age were risk factors for tumor recurrence. Older age led to a lower probability of achieving CSR for thymomatous MG. WHAT THIS STUDY ADDS: This study had a relatively large sample size of patients with thymic epithelial tumors in a single center. We evaluated not only the oncological prognosis, but also neurological outcomes after thymectomy, which was a more comprehensive assessment of surgical effect for thymic epithelial tumors. John Wiley & Sons Australia, Ltd 2020-05-08 2020-07 /pmc/articles/PMC7327686/ /pubmed/32384230 http://dx.doi.org/10.1111/1759-7714.13464 Text en © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Tian, Wenxin
Sun, Yaoguang
Wu, Qingjun
Jiao, Peng
Ma, Chao
Yu, Hanbo
Huang, Chuan
Tong, Hongfeng
Surgical outcomes of 215 patients with thymic epithelial tumors: A single‐center experience
title Surgical outcomes of 215 patients with thymic epithelial tumors: A single‐center experience
title_full Surgical outcomes of 215 patients with thymic epithelial tumors: A single‐center experience
title_fullStr Surgical outcomes of 215 patients with thymic epithelial tumors: A single‐center experience
title_full_unstemmed Surgical outcomes of 215 patients with thymic epithelial tumors: A single‐center experience
title_short Surgical outcomes of 215 patients with thymic epithelial tumors: A single‐center experience
title_sort surgical outcomes of 215 patients with thymic epithelial tumors: a single‐center experience
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327686/
https://www.ncbi.nlm.nih.gov/pubmed/32384230
http://dx.doi.org/10.1111/1759-7714.13464
work_keys_str_mv AT tianwenxin surgicaloutcomesof215patientswiththymicepithelialtumorsasinglecenterexperience
AT sunyaoguang surgicaloutcomesof215patientswiththymicepithelialtumorsasinglecenterexperience
AT wuqingjun surgicaloutcomesof215patientswiththymicepithelialtumorsasinglecenterexperience
AT jiaopeng surgicaloutcomesof215patientswiththymicepithelialtumorsasinglecenterexperience
AT machao surgicaloutcomesof215patientswiththymicepithelialtumorsasinglecenterexperience
AT yuhanbo surgicaloutcomesof215patientswiththymicepithelialtumorsasinglecenterexperience
AT huangchuan surgicaloutcomesof215patientswiththymicepithelialtumorsasinglecenterexperience
AT tonghongfeng surgicaloutcomesof215patientswiththymicepithelialtumorsasinglecenterexperience